Search Results - "PORST, H"

Refine Results
  1. 1

    Results from an online survey investigating ED patients' insights and treatment expectations by Burri, A, Porst, H

    “…Data suggest that the currently available therapies for erectile dysfunction (ED) do not meet all the patients' and their partners' expectations. The aim was…”
    Get full text
    Journal Article
  2. 2

    IC351 (tadalafil, Cialis): update on clinical experience by Porst, H

    “…IC351 (tadalafil, trade name Cialis) is a new representative compound of the second generation of selective phosphodiesterase 5 (PDE-5) inhibitors. The…”
    Get full text
    Journal Article
  3. 3

    Value of prolonged scrotal drainage after penile prosthesis implantation: a multicenter prospective nonrandomized pilot study by Osmonov, D, Ragheb, A M, Petry, T, Eraky, A, Bettocchi, C, Lamers, K G, Van Renterghem, K, Tropmann-Frick, M, Chung, E, Jünemann, K P, Garaffa, G, Porst, H, Mohamed, A G, Wilson, S K

    “…We aimed to understand the risks and benefits of post-inflatable penile prosthesis (IPP) implantation drainage and optimal duration. Our patients were divided…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Oral Agents for the Treatment of Premature Ejaculation: Review of Efficacy and Safety in the Context of the Recent International Society for Sexual Medicine Criteria for Lifelong Premature Ejaculation by McMahon, Chris G., Porst, Hartmut

    Published in Journal of sexual medicine (01-10-2011)
    “…New diagnostic criteria for lifelong premature ejaculation (PE) have been proposed by the International Society of Sexual Medicine (ISSM), including an…”
    Get full text
    Journal Article
  6. 6

    Physicians' attitudes towards androgen replacement therapy for male and female sexual dysfunction by Lowenstein, L, Shechter, A, Porst, H, Tripodi, F, Reisman, Y

    “…Androgen deficiency syndrome is a commonly diagnosed condition. The aim of this study was to investigate common clinical practices of specialists in the field…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Continuation and effectiveness of tadalafil once daily during a 6-month observational study in erectile dysfunction: the EDATE study by Buvat, J, Hatzichristou, D, Boess, F G, Büttner, H, Gehchan, N, Henneges, C, Porst, H

    “…This was the first observational study evaluating treatment continuation, effectiveness and tolerability of tadalafil 5 mg once daily (TAD-OaD) in patients who…”
    Get more information
    Journal Article
  8. 8

    On tree coalgebras and coalgebra presentations by Adámek, J., Porst, H.-E.

    Published in Theoretical computer science (01-01-2004)
    “…For deterministic systems, expressed as coalgebras over polynomial functors, every tree t (an element of the final coalgebra) turns out to represent a new…”
    Get full text
    Journal Article
  9. 9

    The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial by PORST, H, ROSEN, R, PADMA-NATHAN, H, GOLDSTEIN, I, GIULIANO, F, ULBRICH, E, BANDEL, T

    “…Vardenafil, a novel selective phosphodiesterase type 5 inhibitor, was evaluated in its first large-scale at-home trial. A total of 601 men with mild to severe…”
    Get full text
    Journal Article
  10. 10

    Transurethral alprostadil with MUSE (medicated urethral system for erection) vs intracavernous alprostadil--a comparative study in 103 patients with erectile dysfunction by Porst, H

    “…A comparative study in 103 unselected patients with erectile dysfunction between MUSE up to 1000 micrograms and intracavernous Alprostadil (Prostavasin) up to…”
    Get full text
    Journal Article
  11. 11

    Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction by Porst, H

    “…Thirty percent of males afflicted with erectile dysfunction (ED) do not respond to oral drugs, another 15% reveal contraindications to currently available…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erectile dysfunction by Stief, C, Porst, H, Sáenz De Tejada, I, Ulbrich, E, Beneke, M

    “…This randomised, double-blind study assessed the long-term efficacy and tolerability of vardenafil 10 and 20 mg in men with erectile dysfunction (ED). A total…”
    Get more information
    Journal Article
  14. 14

    Genetic association study of the GNB3 C825T, the ACE I/D and the eNOS G894T polymorphisms and the risk to develop erectile dysfunction in a German ED population by Eisenhardt, A., Stief, C., Porst, H., Wetterauer, U., Weidner, W., Rübben, H., Sperling, H.

    Published in Andrologia (01-08-2010)
    “…Summary Erectile dysfunction (ED) is often associated with cardiovascular disorders such as hypertension, coronary heart disease, hypercholesterolaemia and…”
    Get full text
    Journal Article
  15. 15

    Intracavernous Alprostadil Alfadex--an effective and well tolerated treatment for erectile dysfunction. Results of a long-term European study by Porst, H, Buvat, J, Meuleman, E, Michal, V, Wagner, G

    “…Long-term efficacy and safety of Alprostadil-Alfadex (EDEX/VIRIDAL) in intracavernous self-injection therapy for chronical erectile failure was investigated in…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20